AcoArt Orchid® & Dhalia®

Above-the-knee DCB

China's first above-knee drug-coated balloon dilation catheter

AcoArt Orchid® & Dhalia®

Above-the-knee DCB


Exclusive drug-coating technology

AcoArt drug-coated balloon adopts the stable natural excipient matrix— magnesium stearate as the drug carrier. Moreover, the exclusive paclitaxel coating technique significantly reduced drug shedding while being delivered in the vessel

SFA 1.jpg

Data source: Testing results of the third-party laboratory commissioned by Acotec

The complete balloon size distribution optimizes the selection scope

Catheter diameters cover 3mm to 12mm, including the industry-first half-size diameter specification for DCB, with catheter lengths from 20mm to 300mm, far longer than similar products. It not only provides the optimal choice according to the lesion conditions but also improves the health and economic benefits

SFA 2.jpg

Enroll complex lesions with an average lesion length of nearly 15cm. The late lumen loss of over half of the CTO patients is only 0.05mm at 6th month in the DCB group, showing superior efficacy


SFA 4.jpg

1. Chen Zhong,Guo Wei,Jiang Weiliang et al. IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population.[J] .J Endovasc Ther, 2019, 26: 471-478.

2. Rosenfield Kenneth,Jaff Michael R,White Christopher J et al. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.[J] .N Engl J Med, 2015, 373: 145-53.

3. Presented by Prof. Changwei Liu @ CEC 2018. 4. Presented by Prof. Changwei Liu @ CEC 2019. 5. Presented by Prof. Jian Dong @ CEC 2021.

The late lumen loss is only 0.05mm at 6th month in the DCB group, showing superior efficacy

SFA 6个月.jpg

Data source:  Acotec Drug-Coated Balloon Catheter Randomized, Multicenter, Controlled Clinical Study in Femoropopliteal Arteries: Evidence From the AcoArt I Trial,JACC Cardiovasc Interv. 2016 Sep 26;9(18):1941-9.

The 24-month results show that the patency rate of DCB is much higher than that of PTA

SFA 24个月.jpg

Data source: Drug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of 200 Chinese Patients With Severe Femoropopliteal Lesions: 24-Month Results of AcoArt IJACC Cardiovasc Interv. 2018 Dec 10;11(23):2347-2353.

The 5-year long-term results show that the forward safety of DCB is higher than that of PTA

SFA 5年.jpg

Data source: Long-term safety and efficacy of angioplasty of femoropopliteal artery disease with drug-coated balloons from the AcoArt I trialJ Vasc Surg. 2021 Sep;74(3):756-762.e3.

Technical specifications


AcoArt  Orchid® AcoArt  Dhalia® 





Magnesium stearate (lipophilic)

Magnesium stearate (lipophilic)












Max.18 Max.18